Assignment of Assignor's Interest

Recorded: 2024-12-05 Pages: 9

Assignor

G1 THERAPEUTICS, INC.

Executed: 2024-09-18

Assignee

PHARMACOSMOS A/S

ROERVANGSVEJ 30, HOLBAEK, 4300, DENMARK

Covered Property (1)

Targeted Treatment of Cancers with Dysregulated Fibroblast Growth Factor Receptor Signaling

Application: 17/718,052 →

Publication: US 2022/0241275

Related Assignments (2)

Other recorded transfers of the patent in this record — the chain of ownership.